Search results for "Craving"

showing 5 items of 35 documents

Psicologia delle dipendenze sociali. Mondo interno e comunità

2008

dipendenza prevenzione craving
researchProduct

Efficacia di Buprenorfina/Naloxone nel trattamento delle tossicodipendenze: monitoraggio dei pazienti in terapia presso il Ser.T. di Marsala, ASL n. …

2018

Il lavoro sperimentale è stato eseguito nel periodo gennaio 2016-marzo 2017, presso il Ser.T. di Marsala dell’ASL n. 9 di Trapani, sotto la guida del Dott. Gaetano Gurgone e del Prof. Fabio Venturella, lavoro in cui sono stati altresì analizzati i dati relativi agli ultimi cinque anni. Il compito prevalente del Ser.T. è l’assessment, inteso come processo di raccolta, integrazione ed interpretazione delle informazioni.Si esplica attraverso: la diagnosi, la cura, la riabilitazione. Questo lavoro vuole essere quindi il resoconto di 15 mesi di osservazione su pazienti trattati con Buprenorfina/Naloxone,operando un confronto con pazienti trattati con il Metadone.Il campione è costituito da 32 so…

medicine.medical_specialtyMethadone hydrochloridebusiness.industryCravingMental activityWorld healthHeroinBuprenorfina Metadone NaloxoneNaloxonemental disordersSettore BIO/14 - FarmacologiaMedicinemedicine.symptombusinessPsychiatrymedicine.drug
researchProduct

Can transcranial direct current stimulation (tDCS) improve impulsivity in healthy and psychiatric adult populations? A systematic review.

2020

Impulsivity is a multidimensional phenomenon that remains hard to define. It compounds the core pathological construct of many neuropsychiatric illnesses, and despite its close relation to suicide risk, it currently has no specific treatment. Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique whose application results in cognitive function improvement, both in healthy and psychiatric populations. Following PRISMA recommendations, a systematic review of the literature concerning tDCS's effects on impulsive behaviour was performed using the PubMed database. The research was based on the combination of the keyword 'tDCS' with 'impulsivity', 'response i…

medicine.medical_specialtymedicine.medical_treatment[SDV]Life Sciences [q-bio]CravingImpulsivityTranscranial Direct Current Stimulation03 medical and health sciences0302 clinical medicineRisk-TakingmedicineHumansPsychiatryBiological PsychiatryResponse inhibitionCravingPharmacologyTranscranial direct-current stimulationCognition3. Good health030227 psychiatryDorsolateral prefrontal cortex[SDV] Life Sciences [q-bio]Disruptive Impulse Control and Conduct DisordersInhibition Psychologicalmedicine.anatomical_structureDelay DiscountingBrain stimulationImpulsive Behaviormedicine.symptomConstruct (philosophy)PsychologyProgress in neuro-psychopharmacologybiological psychiatry
researchProduct

Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms

2019

Currently, there are no approved pharmacotherapies for addiction to cocaine and other psychostimulant drugs. Several studies have proposed that cannabidiol (CBD) could be a promising treatment for substance use disorders. In the present work, the authors describe the scarce preclinical and human research about the actions of CBD on the effects of stimulant drugs, mainly cocaine and methamphetamine (METH). Additionally, the possible mechanisms underlying the therapeutic potential of CBD on stimulant use disorders are reviewed. CBD has reversed toxicity and seizures induced by cocaine, behavioural sensitization induced by amphetamines, motivation to self-administer cocaine and METH, context- …

medicine.medical_treatmentPharmaceutical ScienceCravingReviewPharmacologyAnalytical ChemistryHealth Risk Behaviorschemistry.chemical_compoundcannabidiol0302 clinical medicineDrug DiscoveryMedicineratrewardmedia_commonResilience PsychologicalMethamphetamineconditioned place preferenceSubstance Withdrawal SyndromeObservational Studies as TopicChemistry (miscellaneous)Molecular Medicineaddictionmedicine.symptomSelf-administrationself-administrationmedicine.drugmicemedia_common.quotation_subjectAmphetamine-Related DisorderscocaineContext (language use)lcsh:QD241-441Cocaine-Related Disorders03 medical and health scienceslcsh:Organic chemistryAnimalsHumansPhysical and Theoretical Chemistrymethamphetaminebusiness.industryAddictionOrganic ChemistryMeth-Conditioned place preferencedigestive system diseasesreinstatement030227 psychiatryStimulantchemistrybusiness030217 neurology & neurosurgeryMolecules
researchProduct

Two‐year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5

2023

Background: The STEP 5 trial (NCT03693430) investigated once-weekly (OW) subcutaneous semaglutide 2.4 mg vs placebo for the treatment of overweight/obesity in adults over 2 years. Methods: Adults w ith B MI ≥ 3 0 k g/m2, or ≥27 kg/m2 and ≥ 1 weight-related comorbidity, without diabetes, were randomized 1:1 to semaglutide 2.4 mg OW or placebo for 104 weeks. Co-primary endpoints related to body weight (BW) changes. Control of eating questionnaire (CoEQ) was assessed in a subgroup from Canada/USA, with scores from 19 individual items grouped into 4 domains: craving control, craving for savory, craving for sweet, or positive mood. P values for exploratory CoEQ data are unadjusted for multiplici…

obesitysemaglutideNutrition and DieteticsEndocrinology Diabetes and MetabolismObesidadInvestigación médicaeating controlMedicine (miscellaneous)Settore MED/13 - Endocrinologiaobesity semaglutide craving control of eatingTratamiento médicoEndocrinologyGlucemiaSTEP 5Control glucémicoSettore MED/49 - Scienze Tecniche Dietetiche ApplicateObesity
researchProduct